DOI QR코드

DOI QR Code

초임계 유체를 이용한 젬시타빈 함유 PLLA/젬시타빈-PLLA 미립자의 제조 및 방출 특성

Preparation of Gemcitabine-Loaded PLLA/Gemcitabine-PLLA Microparticles Using Supercritical Fluid and Their Release Characteristics

  • Hong, Jin-Hee (Department of Chemical Engineering, The University of Suwon) ;
  • Lim, Giobin (Department of Chemical Engineering, The University of Suwon) ;
  • Ryu, Jong-Hoon (Department of Chemical Engineering, The University of Suwon)
  • 투고 : 2014.08.29
  • 심사 : 2014.10.28
  • 발행 : 2014.12.30

초록

In this study, gemcitabine (Gem)-Poly(L-lactic acid) (PLLA) conjugates were synthesized through an amide linkage reaction. Then, the microparticles of Gem-PLLA/PLLA blends containing gemcitabine were prepared using a supercritical fluid process, called aerosol solvent extraction system (ASES). Gemcitabine-loaded Gem-PLLA/PLLA microparticles obtained from the ASES process showed a spherical shape. The amount of gemcitabine released after 30 day incubation in a phosphate buffer solution of pH 7.4 was about 90% of the total amount of gemcitabine present in the product.

키워드

참고문헌

  1. Nussbaumer, S., P. Bonnabry, J. L. Veuthey, and S. Fleury-Souverain (2011) Analysis of anticancer drugs: A review. Talanta 85: 2265-2289. https://doi.org/10.1016/j.talanta.2011.08.034
  2. Nair, L. S. and C. T. Laurencin (2006) Polymers as biomaterials for tissue engineering and controlled drug delivery. Biochem. Eng. Biotechnol. 102: 47-90.
  3. Feng, S. S. and S. Chien (2003) Chemotherapeutic engineering: Application and further development of chemical engineering principles for chemotherapy of cancer and other diseases. Chem. Eng. Sci. 58: 4087-4114. https://doi.org/10.1016/S0009-2509(03)00234-3
  4. Kwon, G. S. (2006) Polymeric Drug Delivery Systems, pp. 93-123. Taylor and Francis Group, LLC, Boca Paton, USA.
  5. Ravi Kumar, M. N. V. and N. Kumar (2001) Polymeric controlled drug-delivery systems: Perspective issues and opportunities. Drug Dev. Ind. Pharm. 27: 1-30. https://doi.org/10.1081/DDC-100000124
  6. Park, J., M. Ye, and K. Park (2005) Biodegradable polymers for microencapsulation of drugs. Molecules 10: 146-161. https://doi.org/10.3390/10010146
  7. Wirk, B. and E. Perez (2006) Role of gemcitabine in breast cancer management: An update. Semin. Oncol. 33: 6-14.
  8. Mangeold, C. (2001) Chemotherapy for advanced non-small cell lung cancer. Semin. Oncol. 28: 1-6. https://doi.org/10.1053/sonc.2001.25736
  9. Maase, H. V. D. (2001) Gemcitabine in advanced bladder canner. Semin. Oncol. 28: 11-14. https://doi.org/10.1053/sonc.2001.24369
  10. Fruscella, E., D. Gallo, G. Ferrandina, G. D'Agostino, and G. Scambia (2003) Gemcitabine: Current role and future options in the treatment of ovarian cancer. Crit. Rev. Oncol. Hematol. 48: 81-88. https://doi.org/10.1016/S1040-8428(03)00119-7
  11. Locher, C., E. Fabre-Guillevin, F. Brunetti, J. Auroux, J. C. Delchier, P. Piedbois, and L. Zelek (2008) Fixed-dose rate gemcitabine in elderly patients with advanced pancreatic cancer: An observational study. Crit. Rev. Oncol. Hematol. 68: 178-182. https://doi.org/10.1016/j.critrevonc.2008.06.010
  12. Joo, H. J., I. I. Jung, G. B. Lim, and J. H. Ryu (2011) Production of gemcitabine-loaded poly(L-lactic acid) microparticles using supercritical carbon dioxide: Effect of process parameters. KSBB J. 26: 69-77. https://doi.org/10.7841/ksbbj.2011.26.1.069
  13. Zhigaltsev, I. V., N. Maurer, F. W. Kim, and P. R. Cullis (2002) Triggered release of doxorubicin following mixing of cationic and anionic liposomes. Biochem. Biophys. Acta 1565: 129-135. https://doi.org/10.1016/S0005-2736(02)00543-6
  14. Jagur-Grodzinski, J. (2009) Polymers for targeted and/or sustained drug delivery. Polym. Adv. Technol. 20: 595-606. https://doi.org/10.1002/pat.1304
  15. Pasut, G. and F. M. Veronese (2007) Polymer-drug conjugation, recent achievements and general strategies. Prog. Polym. Sci. 32: 933-961. https://doi.org/10.1016/j.progpolymsci.2007.05.008
  16. Vicent, M. J. (2007) Polymer-drug conjugates as modulators of cellular apoptosis. AAPS J. 16: E200-E207.
  17. Satchi-Fainaro, R., R. Duncan, and C. M. Barnes (2006) Polymer therapeutics for cancer: Current status and future challenges. Adv. Polym. Sci. 193: 1-65. https://doi.org/10.1007/12_024
  18. Jain, R. A. (2000) The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 21: 2475-2490. https://doi.org/10.1016/S0142-9612(00)00115-0
  19. Li, M., O. Rouaud, and D. Poncelet (2008) Microencapsulation by solvent evaporation: State of the art for process engineering approachs. Int. J. Pharm. 363: 26-39. https://doi.org/10.1016/j.ijpharm.2008.07.018
  20. Yeo, S. D. and E. Kiran (2005) Formation of polymer particles with supercritical fluids: A review. J. Supercrit. Fluids 34: 287-308. https://doi.org/10.1016/j.supflu.2004.10.006
  21. Bahrami, M. and S. Ranjbarian (2007) Production of micro- and nano-composite particles by supercritical carbon dioxide. J. Supercrit. Fluids 40: 263-283. https://doi.org/10.1016/j.supflu.2006.05.006
  22. Ryu, J. H. (2013) Synthesis of gemcitabine-PLLA conjugates and preparation of their microparticles using supercritical fluid. The University of Suwon Theses Collection 27: 149-155.
  23. Jung, J. H., I. I. Jung, H. J. Joo, J. R. Shin, G. B. Lim, and J. H. Ryu (2008) Preparation of biodegradable polymer microparticles containing 5-FU using supercritical carbon dioxide. KSBB J. 23: 452-459.
  24. Yoo, H. S. and T. G. Park (2004) Folate receptor targeted biodegradable polymeric doxorubicin micelles. J. Control. Rel. 96: 273-283. https://doi.org/10.1016/j.jconrel.2004.02.003
  25. Espartero, J. L., I. Rashkov, S. M. Li, N. Manolova, and M. Vert (1996) NMR analysis of low molecular weight poly(lactic acid)s. Macromolecules 29: 3535-3539. https://doi.org/10.1021/ma950529u
  26. Cavallaro, G., L. Mariano, S. Salmaso, P. Caliceti, and G. Gaetano (2006) Folate-mediated targeting of polymeric conjugates of gemcitabine. Int. J. Pharm. 307: 258-269. https://doi.org/10.1016/j.ijpharm.2005.10.015
  27. Vandana, M. and S. K. Sahoo (2010) Long circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancer. Biomaterials 31: 9340-9356. https://doi.org/10.1016/j.biomaterials.2010.08.010
  28. Dorgan, J. R., J. Janzen, M. P. Clayton, S. B. Hait, and D. M. Knauss (2005) Melt rheology of variable L-content poly(lactic-acid). J. Rheol. 49: 607-619. https://doi.org/10.1122/1.1896957
  29. Kim, J. H., S. Y. Lee, B. Y. Kim, J. H. Ryu, and G. B. Lim (2003) Preparation of L-PLA microparticles using pure and cosolventmodified supercritical carbon dioxide. KSBB J. 18: 385-392.
  30. Jung, J. and M. Perrut (2001) Particle design using supercritical fiuids: Literature and patent survey. J. Supercrit. Fluids 20: 179-219. https://doi.org/10.1016/S0896-8446(01)00064-X
  31. Pasquali, I., R. Bettini, and F. Giordano (2008) Supercritical fluid technologies: An innovative approach for manipulating the solid-state of pharmaceuticals. Adv. Drug Del. Rev. 60: 399-410. https://doi.org/10.1016/j.addr.2007.08.030
  32. Bahrami, M. and S. Ranjbarian (2007) Production of micro- and nano-composite particles by supercritical carbon dioxide. J. Supercrit. Fluids 40: 263-283. https://doi.org/10.1016/j.supflu.2006.05.006